SCHEMBL20914845

SCHEMBL20914845

Cc1cc(C(=O)O)cc(C(F)(F)F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TPMT P51580 1/20 0.42
▸ ALKBH5 Q6P6C2 1/20 0.38
▸ SORT1 Q99523 1/20 0.38
▸ HCAR1 Q9BXC0 2/20 0.37
▸ MRGPRX4 Q96LA9 1/20 0.37
▸ RARB P10826 1/20 0.36
▸ TAS2R14 Q9NYV8 1/20 0.36
▸ NOTUM Q6P988 4/20 0.36
▸ RXRA P19793 1/20 0.36
▸ RXRB P28702 1/20 0.36
▸ RXRG P48443 1/20 0.36
▸ TTR P02766 2/20 0.36
▸ KIF11 P52732 1/20 0.36
▸ PTGER4 P35408 1/20 0.36
▸ SRD5A2 P31213 1/20 0.35
▸ ASPH Q12797 1/20 0.35
▸ MYC P01106 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ PTPN7 P35236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7827636 0.82 TPMT (0.54) TPMTHCAR1NOTUMTTRMYC
SCHEMBL627998 0.81 CES2 (0.45) TPMTHCAR1MRGPRX4RXRARXRB
SCHEMBL29738542 0.81 CES2 (0.45) TPMTHCAR1MRGPRX4RXRARXRB
SCHEMBL27250302 0.81 MMP1 (0.37) KIF11
SCHEMBL23526674 0.78 KDM4E (0.40) HCAR1MRGPRX4RXRARXRBRXRG
SCHEMBL29945788 0.78 KDM4E (0.40) HCAR1MRGPRX4RXRARXRBRXRG
SCHEMBL3230982 0.78 TTR (0.48) TPMTHCAR1MRGPRX4RARBNOTUM
SCHEMBL29738557 0.78 TTR (0.48) TPMTHCAR1MRGPRX4RARBNOTUM
SCHEMBL15357730 0.77 CYP3A4 (0.39) TPMTALKBH5SORT1HCAR1MRGPRX4
SCHEMBL2183846 0.76 CES2 (0.48) TPMTHCAR1NOTUMTTRPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11174250-B2 Substituted carboxamides as inhibitors of WDR5 protein-protein binding Propellon Therapeutics Inc. (CA) 2021-11-16 — — US disclosed
US-20190119264-A1 INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING Propellon Therapeutics Inc. (CA) 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174250-B2 Substituted carboxamides as inhibitors of WDR5 protein-protein binding WDR5, WDR82, WDR1 TPMT 841/4885ALKBH5 1690/4885SORT1 4704/4885
US-20190119264-A1 INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING WDR5, WDR82, WDR1 TPMT 941/4885ALKBH5 3210/4885SORT1 4316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback